64-65-3 Usage
Uses
CNS stimulant;GABA antagonist
Brand name
Megimide
(Abbott).
General Description
White crystalline solid. Sublimes at 212°F and 200 mm pressure.
Air & Water Reactions
Insoluble in water.
Reactivity Profile
3-ETHYL-3-METHYLGLUTARIMIDE is an amide. Amides/imides react with azo and diazo compounds to generate toxic gases. Flammable gases are formed by the reaction of organic amides/imides with strong reducing agents. Amides are very weak bases (weaker than water). Imides are less basic yet and in fact react with strong bases to form salts. That is, they can react as acids. Mixing amides with dehydrating agents such as P2O5 or SOCl2 generates the corresponding nitrile. The combustion of these compounds generates mixed oxides of nitrogen (NOx).
Health Hazard
ACUTE/CHRONIC HAZARDS: When heated to decomposition it emits toxic fumes.
Fire Hazard
Flash point data for 3-ETHYL-3-METHYLGLUTARIMIDE are not available. 3-ETHYL-3-METHYLGLUTARIMIDE is probably not flammable.
Safety Profile
Poison by ingestion,
intravenous, intraperitoneal, intramuscular,
subcutaneous, and parented routes. Human
systemic effects by ingestion: wakefulness,
hallucinations, distorted perceptions, toxic
psychosis. An analeptic, central nervous
system stimulant; used to counteract
barbiturate poisoning. When heated to
decomposition it emits toxic fumes of NOx.
Check Digit Verification of cas no
The CAS Registry Mumber 64-65-3 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 6 and 4 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 64-65:
(4*6)+(3*4)+(2*6)+(1*5)=53
53 % 10 = 3
So 64-65-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H13NO2/c1-3-8(2)4-6(10)9-7(11)5-8/h3-5H2,1-2H3,(H,9,10,11)
64-65-3Relevant articles and documents
AMIDOALKYLPIPERAZINYL DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES
-
Page/Page column 28; 29, (2013/03/26)
The invention relates to novel amidoalkylpiperazinyl derivatives of tricyclic heterocyclic systems of general formula (I), wherein Z represents -NH- and X represents -S-, or Z represents -S- and X represents >C=C1 represents H or -CH3, R6 and R7 both represent H, n is an integer from 0 to 4 inclusive, G represents a cyclic amide or imide moiety, and optical isomers, geometric isomers, and pharmaceutically acceptable salts thereof. The compounds may be useful for the treatment and/or prevention of the central nervous system disorders.